MDK and neoplasm: Unlike TGF-β-mediated immunosuppression, which primarily acts via Treg activation and myeloid suppression, MDK-NCL signaling may establish a distinct immunosuppressive niche by interacting with tumor-associated macrophages (TAMs) and fibroblasts.